Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.32Price to Sales
VS
Market
Sector
Industry
History
$ 0.06Close
$ 0.04 - $ 0.83 52-Week Range
Ticker Information
Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADAPTIMMUNE THERAPEUTICS PLC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADAP - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 20.72M | 0.32 | $ 65.08M |
| 3/31/2025 | $ 66.4M | 0.37 | $ 179.64M |
| 12/31/2024 | $ 71.4M | 0.4 | $ 178.03M |
| 9/30/2024 | $ 197.68M | 1.13 | $ 175.04M |
| 6/30/2024 | $ 279.32M | 1.97 | $ 141.46M |
| 3/31/2024 | $ 317.53M | 17.3 | $ 18.36M |
| 12/31/2023 | $ 422.92M | 7.02 | $ 60.28M |
| 9/30/2023 | $ 128.13M | 1.8 | $ 71.08M |
| 6/30/2023 | $ 192.63M | 2.72 | $ 70.77M |
| 3/31/2023 | $ 227.47M | 3.2 | $ 71.17M |
Key Performance Insights, Last 5 Years
- ADAPTIMMUNE THERAPEUTICS PLC's latest trailing twelve months (TTM) P/S stands at 258.64.
- Over the past 5 years, ADAPTIMMUNE THERAPEUTICS PLC's average P/S has been 54.51.
- The median P/S for ADAPTIMMUNE THERAPEUTICS PLC during this period was 12.68
- ADAPTIMMUNE THERAPEUTICS PLC reached its highest P/S over the past 5 years at 258.64.
- The lowest P/S recorded by ADAPTIMMUNE THERAPEUTICS PLC in the same timeframe 0.32
ADAPTIMMUNE THERAPEUTICS PLC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: Market Cap [ $ 823.52M ] / Revenues [ $ 3.18M ]
(=) P/S [ 258.64 ] ADAP - Price to Sales, Last 5 years
0.32
Minimum
Jun 30, 2025
258.64
Maximum
Sep 30, 2020
54.51
Average
12.68
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |